Literature DB >> 25052812

Code blue: Acinetobacter baumannii, a nosocomial pathogen with a role in the oral cavity.

A M Richards1, Y Abu Kwaik, R J Lamont.   

Abstract

Actinetobacter baumannii is an important nosocomial pathogen that can cause a wide range of serious conditions including pneumonia, meningitis, necrotizing fasciitis and sepsis. It is also a major cause of wound infections in military personnel injured during the conflicts in Afghanistan and Iraq, leading to its popular nickname of 'Iraqibacter'. Contributing to its success in clinical settings is resistance to environmental stresses such as desiccation and disinfectants. Moreover, in recent years there has been a dramatic increase in the number of A. baumannii strains with resistance to multiple antibiotic classes. Acinetobacter baumannii is an inhabitant of oral biofilms, which can act as a reservoir for pneumonia and chronic obstructive pulmonary disease. Subgingival colonization by A. baumannii increases the risk of refractory periodontitis. Pathogenesis of the organism involves adherence, biofilm formation and iron acquisition. In addition, A. baumannii can induce apoptotic cell death in epithelial cells and kill hyphal forms of Candida albicans. Virulence factors that have been identified include pili, the outer membrane protein OmpA, phospholipases and extracellular polysaccharide. Acinetobacter baumannii can sense blue light through a blue-light sensing using flavin (BLUF) domain protein, BlsA. The resulting conformational change in BlsA leads to changes in gene expression, including virulence genes.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Acinetobacter; infection models; oral microbiology; periodontal disease; respiratory tract microbiology

Mesh:

Substances:

Year:  2014        PMID: 25052812      PMCID: PMC4617346          DOI: 10.1111/omi.12072

Source DB:  PubMed          Journal:  Mol Oral Microbiol        ISSN: 2041-1006            Impact factor:   3.563


  124 in total

1.  Subgingival microbiota of Brazilian subjects with untreated chronic periodontitis.

Authors:  Ana Paula V Colombo; Ricardo P Teles; Maria Cynésia Torres; Renata Souto; Wilson Júnior Rosalém; Maria Cláudia S Mendes; Milton Uzeda
Journal:  J Periodontol       Date:  2002-04       Impact factor: 6.993

2.  Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis.

Authors:  Anna C Jacobs; Indriati Hood; Kelli L Boyd; Patrick D Olson; John M Morrison; Steven Carson; Khalid Sayood; Peter C Iwen; Eric P Skaar; Paul M Dunman
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

3.  "Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.

Authors:  Dror Marchaim; Federico Perez; Jiha Lee; Suchitha Bheemreddy; Andrea M Hujer; Susan Rudin; Kayoko Hayakawa; Paul R Lephart; Christopher Blunden; Maryann Shango; Michelle L Campbell; Jastin Varkey; Palaniappan Manickam; Diixa Patel; Jason M Pogue; Teena Chopra; Emily T Martin; Sorabh Dhar; Robert A Bonomo; Keith S Kaye
Journal:  Am J Infect Control       Date:  2012-02-10       Impact factor: 2.918

4.  Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii.

Authors:  Chen Niu; Katy M Clemmer; Robert A Bonomo; Philip N Rather
Journal:  J Bacteriol       Date:  2008-02-15       Impact factor: 3.490

5.  Genetic organization of an Acinetobacter baumannii chromosomal region harbouring genes related to siderophore biosynthesis and transport.

Authors:  Caleb W Dorsey; Marcelo E Tolmasky; Jorge H Crosa; Luis A Actis
Journal:  Microbiology       Date:  2003-05       Impact factor: 2.777

Review 6.  Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections.

Authors:  Matthieu Eveillard; Marie Kempf; Olivier Belmonte; Hélène Pailhoriès; Marie-Laure Joly-Guillou
Journal:  Int J Infect Dis       Date:  2013-05-11       Impact factor: 3.623

7.  The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection.

Authors:  Pradeep Bist; Neha Dikshit; Tse Hsien Koh; Alessandra Mortellaro; Thuan Tong Tan; Bindu Sukumaran
Journal:  Infect Immun       Date:  2013-12-23       Impact factor: 3.441

8.  Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice.

Authors:  Hongyu Qiu; Rhonda Kuolee; Greg Harris; Wangxue Chen
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

9.  Epidemiology of rifampin ADP-ribosyltransferase (arr-2) and metallo-beta-lactamase (blaIMP-4) gene cassettes in class 1 integrons in Acinetobacter strains isolated from blood cultures in 1997 to 2000.

Authors:  Elizabeth T S Houang; Yiu-Wai Chu; Wai-Sing Lo; Ka-Yi Chu; Augustine F B Cheng
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

10.  Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program.

Authors:  Shu-Chen Kuo; Shan-Chwen Chang; Hui-Ying Wang; Jui-Fen Lai; Pei-Chen Chen; Yih-Ru Shiau; I-Wen Huang; Tsai-Ling Yang Lauderdale
Journal:  BMC Infect Dis       Date:  2012-08-28       Impact factor: 3.090

View more
  10 in total

1.  Characterization and Inhibition of 1-Deoxy-d-Xylulose 5-Phosphate Reductoisomerase: A Promising Drug Target in Acinetobacter baumannii and Klebsiella pneumoniae.

Authors:  Haley S Ball; Misgina B Girma; Mosufa Zainab; Iswarduth Soojhawon; Robin D Couch; Schroeder M Noble
Journal:  ACS Infect Dis       Date:  2021-10-21       Impact factor: 5.578

2.  Candida albicans Airway Colonization Facilitates Subsequent Acinetobacter baumannii Pneumonia in a Rat Model.

Authors:  Xiaojiang Tan; Ruilan Chen; Song Zhu; Huijun Wang; Dongxing Yan; Xiangdong Zhang; Dimitrios Farmakiotis; Eleftherios Mylonakis
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

3.  Transcriptome analysis of Porphyromonas gingivalis and Acinetobacter baumannii in polymicrobial communities.

Authors:  D P Miller; Q Wang; A Weinberg; R J Lamont
Journal:  Mol Oral Microbiol       Date:  2018-08-03       Impact factor: 3.563

Review 4.  A practical guide to the oral microbiome and its relation to health and disease.

Authors:  K Krishnan; T Chen; B J Paster
Journal:  Oral Dis       Date:  2016-07-04       Impact factor: 3.511

Review 5.  Fungal-Bacterial Interactions in Health and Disease.

Authors:  Wibke Krüger; Sarah Vielreicher; Mario Kapitan; Ilse D Jacobsen; Maria Joanna Niemiec
Journal:  Pathogens       Date:  2019-05-21

Review 6.  Presence of non-oral bacteria in the oral cavity.

Authors:  Nawel Zaatout
Journal:  Arch Microbiol       Date:  2021-03-31       Impact factor: 2.552

Review 7.  Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.

Authors:  Shio-Shin Jean; Dorji Harnod; Po-Ren Hsueh
Journal:  Front Cell Infect Microbiol       Date:  2022-03-15       Impact factor: 5.293

8.  Intensive Periodontal Treatment Reduces Risk of Infection-Related Hospitalization in Hemodialysis Population: A Nationwide Population-Based Cohort Study.

Authors:  Shih-Ting Huang; Cheng-Li Lin; Tung-Min Yu; Ming-Ju Wu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

9.  Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?

Authors:  Shio-Shin Jean; Tai-Chin Hsieh; Wen-Sen Lee; Po-Ren Hsueh; Chin-Wan Hsu; Carlos Lam
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

10.  An insight into the emergence of Acinetobacter baumannii as an oro-dental pathogen and its drug resistance gene profile - An in silico approach.

Authors:  J Vijayashree Priyadharsini; A S Smiline Girija; A Paramasivam
Journal:  Heliyon       Date:  2018-12-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.